Maxlinear (MXL) EBIT (2010 - 2026)

Maxlinear has disclosed EBIT across 17 years of filings, most recently posting -$17.2 million for Q1 2026.

• In Q1 2026, EBIT rose 62.67% year-over-year to -$17.2 million; the TTM figure through Mar 2026 stood at -$98.0 million (up 49.7% YoY), while the FY2025 annual figure was -$126.9 million, up 43.19% from the prior year.
• EBIT retreated to -$17.2 million in Q1 2026, from -$14.9 million in the prior quarter.
• Over the last five years, EBIT for MXL reached as high as $51.9 million in Q3 2022 and fell as low as -$74.6 million in Q1 2024.
• The 5-year median for EBIT is -$17.8 million (2023), against an average of -$13.3 million.
• Annual changes were most pronounced in 2022 — EBIT jumped 1669.83% — and 2024, when it plunged 587.55%.
• A 5-year view of EBIT shows it stood at $41.2 million in 2022, then plunged by 201.41% to -$41.7 million in 2023, then climbed by 1.37% to -$41.2 million in 2024, then surged by 63.83% to -$14.9 million in 2025, then dropped by 15.56% to -$17.2 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered -$17.2 million, -$14.9 million, and -$41.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.